Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 2
2015 4
2016 2
2017 3
2018 2
2019 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy.
Castiglione F, Dell'Oglio P, Tosco L, Everaerts W, Albersen M, Hakim L, Van den Broeck T, Moris L, Claessens F, Briganti A, Montorsi F, Van Poppel H, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Castiglione F, et al. Prostate. 2017 Jan;77(1):3-9. doi: 10.1002/pros.23242. Epub 2016 Aug 16. Prostate. 2017. PMID: 27527377
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study.
Joniau S, Briganti A, Gontero P, Gandaglia G, Tosco L, Fieuws S, Tombal B, Marchioro G, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, Van Poppel H, Spahn M; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Eur Urol. 2015 Jan;67(1):157-164. doi: 10.1016/j.eururo.2014.01.020. Epub 2014 Jan 25. Eur Urol. 2015. PMID: 24486307
Results of surgery for high-risk prostate cancer.
Joniau S, Tosco L, Briganti A, Vanden Broeck T, Gontero P, Karnes RJ, Spahn M, Van Poppel H; European Multicenter Prostate Cancer Clinical and Translational research group. Joniau S, et al. Curr Opin Urol. 2013 Jul;23(4):342-8. doi: 10.1097/MOU.0b013e3283620f60. Curr Opin Urol. 2013. PMID: 23702565 Review.
Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease.
Spahn M, Briganti A, Capitanio U, Kneitz B, Gontero P, Karnes JR, Schubert M, Montorsi F, Scholz CJ, Bader P, van Poppel H, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research Group. Spahn M, et al. J Urol. 2012 Jul;188(1):84-90. doi: 10.1016/j.juro.2012.02.2572. Epub 2012 May 12. J Urol. 2012. PMID: 22578727 Clinical Trial.
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer.
Martini A, Gandaglia G, Karnes RJ, Zaffuto E, Bianchi M, Gontero P, Chlosta P, Gratzke C, Graefen M, Tilki D, Cucchiara V, Mirone V, Kneitz B, Sanchez Salas R, Van Der Poel H, Tombal B, Spahn M, Joniau TS, Montorsi F, Briganti A; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT). Martini A, et al. Eur Urol Oncol. 2019 Jul;2(4):456-463. doi: 10.1016/j.euo.2018.12.002. Epub 2018 Dec 24. Eur Urol Oncol. 2019. PMID: 31277783
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A, Spahn M, Joniau S, Gontero P, Bianchi M, Kneitz B, Chun FK, Sun M, Graefen M, Abdollah F, Marchioro G, Frohenberg D, Giona S, Frea B, Karakiewicz PI, Montorsi F, Van Poppel H, Jeffrey Karnes R; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Briganti A, et al. Eur Urol. 2013 Apr;63(4):693-701. doi: 10.1016/j.eururo.2012.08.054. Epub 2012 Sep 5. Eur Urol. 2013. PMID: 22959192
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.
Joniau S, Spahn M, Briganti A, Gandaglia G, Tombal B, Tosco L, Marchioro G, Hsu CY, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, van Poppel H, Gontero P; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Eur Urol. 2015 Feb;67(2):319-25. doi: 10.1016/j.eururo.2014.03.013. Epub 2014 Mar 21. Eur Urol. 2015. PMID: 24684960
Natural history of surgically treated high-risk prostate cancer.
Briganti A, Karnes RJ, Gandaglia G, Spahn M, Gontero P, Tosco L, Kneitz B, Chun FK, Zaffuto E, Sun M, Graefen M, Marchioro G, Frohneberg D, Giona S, Karakiewicz PI, Van Poppel H, Montorsi F, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Briganti A, et al. Urol Oncol. 2015 Apr;33(4):163.e7-13. doi: 10.1016/j.urolonc.2014.11.018. Epub 2015 Feb 7. Urol Oncol. 2015. PMID: 25665508
Current role of surgery for high risk prostate cancer.
Joniau S, Van der Eeckt K, Briganti A, Gontero P, Van Bruwaene S, Jeffrey Karnes R, Spahn M, Van Poppel H; European Multicenter Prostate Cancer Clinical and Translational research Group (EMPaCT). Joniau S, et al. Arch Esp Urol. 2013 Apr;66(3):259-73, 259-74. Arch Esp Urol. 2013. PMID: 23648745 Review. English, Spanish.
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT). Tosco L, et al. Eur Urol Focus. 2018 Apr;4(3):369-375. doi: 10.1016/j.euf.2016.12.008. Epub 2017 Jan 17. Eur Urol Focus. 2018. PMID: 28753838 Clinical Trial.
13 results